Elentra Nutrition^® Co Q10 + Vitamin C (Capsules) Instructions for Use

Marketing Authorization Holder

Grotex, LLC (Russia)

Dosage Form

Elentra Nutrition Coenzyme Q₁₀ + Vitamin C

Capsules 100 mg+20 mg: 30 pcs.

Dosage Form, Packaging, and Product Composition

Capsules weighing 316 mg.

	1 dose (1 caps.)	Daily Intake Level	% of AIL*, RDI
Ubidecarenone (coenzyme Q₁₀)	100 mg	30 mg-100 mg*	333%**
Ascorbic acid (vit. C)	20 mg	60 mg-900 mg**	33%*

* RDI – recommended daily intake according to TR TS 022/2011, Appendix 2;
** AIL – adequate intake level;
*** upper permissible daily intake level
According to the “Unified Sanitary-Epidemiological and Hygienic Requirements for Goods Subject to Sanitary-Epidemiological Surveillance (Control)”, Appendix 5.

Excipients: hypromellose capsule (E464, carrier), microcrystalline cellulose (E460i, carrier), magnesium stearate (E470, anticaking agent).

30 pcs. – polymer bottles.

Therapeutic Category

Dietary supplement – additional source of antioxidants

Properties

Dietary supplement. Ubidecarenone and vitamin C are essential components for protecting cellular structures from adverse environmental influences. When acting together, the effectiveness of these substances is highest.

Ubidecarenone (ubiquinone, coenzyme Q₁₀) is an antioxidant agent. It has cardiotonic, cardioprotective, adaptogenic, and immunostimulating effects. It helps restore physical performance, increases the body’s ability to adapt to increased loads, stress effects, and hypoxia.

Vitamin C helps increase the body’s resistance to infections; improves iron absorption, promoting its deposition in the reduced form. It has antioxidant properties. The product replenishes the physiological need for ascorbic acid in addition to the diet, balanced taking into account the daily requirement.

Scope of Application

For the prevention and as an additional remedy for diseases of the cardiovascular system, chronic fatigue syndrome.

ICD codes

Open the list of ICD codes

ICD-10 code	Indication
F48.0	Neurasthenia
I99	Other and unspecified disorders of the circulatory system
R53	Malaise and fatigue

ICD-11 code	Indication
6A8Z	Affective disorders, unspecified
BC40.Z	Acquired atrial abnormality, unspecified
BC41.Z	Acquired ventricular abnormality, unspecified
BE2Z	Diseases of the circulatory system, unspecified
EF20.Z	Acquired anomalies of the skin’s blood vessels, unspecified
MG22	Asthenia
MG25	Malaise

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Take orally. Doses and duration of treatment are set individually depending on the indications and the product used.

Side effects

Possible allergic reactions.

Contraindications

Hypersensitivity to the components of the product used.

Use during pregnancy and breastfeeding

During pregnancy and breastfeeding, only products intended for pregnant women and nursing mothers should be used.

Special instructions

This is not a medicinal product.

Before using the product, consult a doctor.

Do not exceed the recommended dose of the product used.

In children, only dietary supplements intended for the corresponding age group should be used.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer